Pitt M, Olvera-Barrios A, Anderson J, Bolter L, Chambers R, Warwick A
Diabetologia. 2025; .
PMID: 40072536
DOI: 10.1007/s00125-025-06379-6.
Chen Y, Meng Y, Tan M, Ma J, Zhu J, Ji M
BMC Ophthalmol. 2025; 25(1):119.
PMID: 40065310
PMC: 11892156.
DOI: 10.1186/s12886-025-03892-5.
Pei X, Li Z
BMJ Public Health. 2025; 3(1):e001353.
PMID: 40017934
PMC: 11812885.
DOI: 10.1136/bmjph-2024-001353.
Mourao D, Santos G, Duarte G
Einstein (Sao Paulo). 2025; 23:eAO1213.
PMID: 40008736
PMC: 11869789.
DOI: 10.31744/einstein_journal/2025AO1213.
Flindris K, Lagkada V, Christodoulou A, Gazouli M, Moschos M, Markozannes G
Biomedicines. 2025; 13(2).
PMID: 40002753
PMC: 11852632.
DOI: 10.3390/biomedicines13020341.
Perceptions of diabetic retinopathy patients on the management of diabetic retinopathy (DR) in South Tarawa, Kiribati: A qualitative study.
Angirerei-Farran T, Mohammadnezhad M, Alnababatah K, Salusalu M
PLOS Glob Public Health. 2025; 5(1):e0004103.
PMID: 39836696
PMC: 11750083.
DOI: 10.1371/journal.pgph.0004103.
Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion.
Chen Q, Chen J, Liu Y, Qi S, Huang L
Extracell Vesicles Circ Nucl Acids. 2024; 4(3):502-517.
PMID: 39698026
PMC: 11648477.
DOI: 10.20517/evcna.2023.32.
Factors associated with the uptake and utilisation of diabetic retinopathy screening services in sub-Saharan Africa: A scoping review.
Nwaoha I, Balibuno A, Ibrahim N
PLoS One. 2024; 19(12):e0315367.
PMID: 39671351
PMC: 11643260.
DOI: 10.1371/journal.pone.0315367.
Dysregulation of amino acids balance as potential serum-metabolite biomarkers for diagnosis and prognosis of diabetic retinopathy: a metabolomics study.
Amiri-Dashatan N, Etemadi S, Besharati S, Farahani M, Moghaddam A
J Diabetes Metab Disord. 2024; 23(2):2031-2042.
PMID: 39610496
PMC: 11599686.
DOI: 10.1007/s40200-024-01462-y.
Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: a systematic review and meta-analysis.
Wondmeneh T, Mohammed J
Sci Rep. 2024; 14(1):28266.
PMID: 39550444
PMC: 11569147.
DOI: 10.1038/s41598-024-78596-9.
Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy.
Ren M, Xu Q, Luan J, Ni Y, Xie B
Acta Diabetol. 2024; .
PMID: 39508857
DOI: 10.1007/s00592-024-02400-3.
Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.
Song Y, Yin C, Kong N
Int J Nanomedicine. 2024; 19:10767-10784.
PMID: 39469447
PMC: 11514697.
DOI: 10.2147/IJN.S475234.
The application and clinical translation of the self-evolving machine learning methods in predicting diabetic retinopathy and visualizing clinical transformation.
Li B, Hu L, Zhang S, Li S, Tang W, Chen G
Front Endocrinol (Lausanne). 2024; 15:1429974.
PMID: 39363895
PMC: 11446766.
DOI: 10.3389/fendo.2024.1429974.
Management of Microcomplications of Diabetes Mellitus: Challenges, Current Trends, and Future Perspectives in Treatment.
Yapislar H, Gurler E
Biomedicines. 2024; 12(9).
PMID: 39335472
PMC: 11429415.
DOI: 10.3390/biomedicines12091958.
In vivo and computational investigation of butin against alloxan-induced diabetes via biochemical, histopathological, and molecular interactions.
Bukhari H, Afzal M, Al-Abbasi F, Sheikh R, Alqurashi M, Bawadood A
Sci Rep. 2024; 14(1):20633.
PMID: 39232184
PMC: 11374895.
DOI: 10.1038/s41598-024-71577-y.
The Association between ADIPOQ Gene Polymorphisms and Diabetic Retinopathy Risk: A Systematic Review and Meta-Analysis.
Flindris K, Markozannes G, Moschos M, Gazouli M, Christodoulou A, Tsilidis K
Medicina (Kaunas). 2024; 60(8).
PMID: 39202535
PMC: 11356243.
DOI: 10.3390/medicina60081254.
Müller Cells Harboring Exosomal lncRNA OGRU Modulate Microglia Polarization in Diabetic Retinopathy by Serving as miRNA Sponges.
Fu S, Sun W, Liu L, Xiao J, Xiong J, Hu Y
Diabetes. 2024; 73(11):1919-1934.
PMID: 39178104
PMC: 11493765.
DOI: 10.2337/db23-1015.
Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome.
Qiao L, Yi S, Li T, Pan X, Wang G, Liu X
J Diabetes Investig. 2024; 15(10):1365-1376.
PMID: 39171660
PMC: 11442751.
DOI: 10.1111/jdi.14292.
Time above range and no coefficient of variation is associated with diabetic retinopathy in individuals with type 1 diabetes and glycated hemoglobin within target.
Sebastian-Valles F, Martinez-Alfonso J, Arranz Martin J, Jimenez-Diaz J, Hernando Alday I, Navas-Moreno V
Acta Diabetol. 2024; 62(2):205-214.
PMID: 39105807
DOI: 10.1007/s00592-024-02347-5.
Diabetic retinopathy incidence, predictors and its association with longitudinal fasting blood sugar level changes among diabetes mellitus patients in Ethiopia: joint model.
Abuhay H, Lakew A, Wolde H, Mengistu B, Legesse M, Yenit M
Front Endocrinol (Lausanne). 2024; 15:1363757.
PMID: 39040673
PMC: 11260754.
DOI: 10.3389/fendo.2024.1363757.